Newcastle disease virus: global distribution, molecular insights and implications for biotechnology and translational Research

View at publisher Summarise with VIRAT
Authors: Alaaeldin Mohamed Saad, Ahmed Mostafa, Luis Martínez‐Sobrido
Cited by: 0
References: 239

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Newcastle disease virus (NDV) is the causative agent of Newcastle disease (ND), which is a highly contagious and economically significant poultry illness. High rates of morbidity and mortality characterize the ND disease, and it remains endemic in many developing regions. Despite its detrimental impact on poultry, genetically engineered attenuated forms of NDV show promise for biomedical research and therapy. NDV has been used as a vaccine viral vector to protect both humans and animals from various pathogen infections, and it is being explored for its oncolytic properties in cancer treatment. The therapeutic use of NDV as a vaccine vector is attributed to the feasibility of generating recombinant attenuated viruses using reverse genetics (RG) approaches. These recombinant NDV viruses have demonstrated safety, genetic stability, immunogenicity, and protection efficacy in both preclinical and clinical studies. Moreover, NDV can stimulate robust antitumor immune responses, further supporting its potential as an oncolytic therapy. This review aims to provide an overview of NDV, including its biology, global epidemiology, and recent developments in RG technologies. The discussion highlights the role of NDV in disease control and therapeutic innovation, emphasizing its potential as a versatile tool for combating infectious and noninfectious diseases in poultry, livestock, and humans.

Fields of Study & Subjects

Virology and Viral Diseases Virus-based gene therapy research Poxvirus research and outbreaks

Publication details

Journal / source
Future Virology
Volume
21
Issue
3
Pages
189–209
Publication date
4 March 2026
Language
EN